Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CYCLACEL PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: CYCC

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.000 Buy 3
    30 Days Ago 2.000 Buy 2
    60 Days Ago 2.000 Buy 2
    90 Days Ago 2.000 Buy 2
    120 Days Ago 2.000 Buy 2

  • Analyst Ratings: CYCC

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Merriman — Buy 10/27/2009 —
    Piper Jaffray — Buy 08/12/2008 5.00
    Cantor Fitzgerald — Buy 03/12/2008 9.00
    Collins Stewart — Buy 03/12/2008 13.00
    Needham & Co — Buy 03/12/2008 7.00
    Cantor Fitzgerald — Buy 11/27/2007 10.50
    Cantor Fitzgerald — Buy 08/10/2007 14.00
    Needham & Co — Buy 06/04/2007 12.00
    Lazard Capital — Buy 04/23/2007 11.00
    Cantor Fitzgerald — Buy 04/10/2007 12.00
    Needham & Co — Buy 07/10/2006 9.00